Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Berkeley Lights, Inc. (BLI : NSDQ)

• Company Description    Berkeley Lights Inc. is a Digital Cell Biology company. It focuses on development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights Inc. is based in EMERYVILLE, Calif. Number of Employees: 100

• Price / Volume Information    Yesterday's Closing Price: $4.98 Daily Weekly Monthly 20 Day Moving Average: 1,199,309 shares Shares Outstanding: 67.83 (millions) Market Capitalization: $337.78 (millions) Beta: 2.40 52 Week High: $51.28 52 Week Low: $3.66 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.86% 3.08% 12 Week -32.88% -24.57% Year To Date -72.61% -66.54%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5858 HORTON STREET SUITE 320 - EMERYVILLE,CA 94608 USA ph: 510-858-2855 fax: - ir@berkeleylights.com http://www.berkeleylights.com

• General Corporate Information    Officers Eric Hobbs - Chief Executive Officer Kurt Wood - Chief Financial Officer John Chiminski - Director Jessica Hopfield - Director Siddhartha Kadia - Director Peer Information Berkeley Lights, Inc. (CORR.) Berkeley Lights, Inc. (RSPI) Berkeley Lights, Inc. (CGXP) Berkeley Lights, Inc. (BGEN) Berkeley Lights, Inc. (GTBP) Berkeley Lights, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 084310101 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/10/22 Share - Related Items Shares Outstanding: 67.83 Most Recent Split Date: (:1) Beta: 2.40 Market Capitalization: $337.78 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.30 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.14 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.75 Price/Cash Flow: - Price / Sales: 3.88 EPS Growth vs. Year Ago Period: -33.33% vs. Previous Quarter: -23.08% Sales Growth vs. Year Ago Period: 8.47% vs. Previous Quarter: -12.85% ROE 03/31/22 - -36.42 12/31/21 - -31.78 09/30/21 - -28.16 ROA 03/31/22 - -27.03 12/31/21 - -24.17 09/30/21 - -22.05 Current Ratio 03/31/22 - 7.52 12/31/21 - 7.04 09/30/21 - 7.17 Quick Ratio 03/31/22 - 6.95 12/31/21 - 6.60 09/30/21 - 6.78 Operating Margin 03/31/22 - -89.36 12/31/21 - -84.00 09/30/21 - -78.76 Net Margin 03/31/22 - -89.36 12/31/21 - -84.00 09/30/21 - -78.76 Pre-Tax Margin 03/31/22 - -89.42 12/31/21 - -84.06 09/30/21 - -78.61 Book Value 03/31/22 - 2.85 12/31/21 - 3.09 09/30/21 - 3.26 Inventory Turnover 03/31/22 - 2.07 12/31/21 - 2.25 09/30/21 - 2.39 Debt-to-Equity 03/31/22 - 0.10 12/31/21 - 0.09 09/30/21 - 0.09 Debt-to-Capital 03/31/22 - 9.29 12/31/21 - 8.67 09/30/21 - 8.23

Powered by Zacks Investment Research ©